Reiko Horikawa

23PUBLICATIONS
90CO-AUTHORS
Welfare, insurance, disability and social security lawChild and adolescent developmentPublic health nutritionPharmaceutical delivery technologiesNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 15, 2025
Seven-year Safety and Efficacy of Somapacitan in Children With GH Deficiency: Final Results From REAL 3.

Lars Sävendahl, Tadej Battelino, Michael Højby

|Dec 03, 2025
Clinical practice guidelines for the management of differences of sex development in Japan.

Tomohiro Ishii, Kenichi Kashimada, Masanobu Kawai

|Nov 24, 2025
Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.

Koji Muroya, Masanobu Kawai, Hiroyuki Yamagishi

|Nov 03, 2025
Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 study.

Reiko Horikawa, Toshiaki Tanaka, Yukihiro Hasegawa

|Sep 05, 2025
Trends In Reported Outcomes for Growth Hormone Therapy In Children With Growth Hormone Deficiency.

Xanthippi Tseretopoulou, Jiajia Chen, Angela Lucas-Herald

|May 28, 2025
Improvement in body composition of Japanese participants with Prader-Willi syndrome following somatropin treatment: an open-label, multi cohort Phase 3 study.

Masanobu Kawai, Nobuyuki Murakami, Reiko Horikawa

Pageof 4

Frequent Collaborators

5 joint publications

Agnès Linglart

5 joint publications

Bradley S Miller

5 joint publications

Masanobu Kawai

4 joint publications

Michael Højby Rasmussen